Physician profile
Anthony Mozer
NPI 1730446915
$42,758.73
in general payments reported to CMS, 2019-2025
26 companies · $488 in 2025
The $488 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,322 · 2020: $522 · 2021: $2,208 · 2022: $13K · 2023: $16K · 2024: $4,974 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $15K · Food and Beverage: $3,808 · Travel and Lodging: $2,258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $15,000.00 |
| Food and Beverage | $3,807.63 |
| Travel and Lodging | $2,258.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $35,385.74 | 2019-2024 | Da Vinci Surgical System |
| Atricure, INC. | $3,445.84 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $1,221.70 | 2020-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Abiomed | $983.28 | 2019-2021 | |
| Abbott Laboratories | $502.94 | 2019-2020 | |
| Medtronic, INC. | $159.52 | 2023-2025 | Endurant Iis, Penditure, Penditure |
| Chiesi USA, INC. | $152.10 | 2023-2025 | Cleviprex, Kengreal |
| Ethicon US, LLC | $148.06 | 2021-2024 | Evarrest, Surgicel Nu-Knit, Vistaseal |
| Medical Device Business Services, INC. | $107.69 | 2021 | |
| La Jolla Pharmaceutical Company | $73.30 | 2023-2024 | Giapreza |
| Stryker Corporation | $70.84 | 2022-2024 | Na |
| Siemens Medical Solutions USA, INC. | $67.62 | 2021 | |
| Getinge USA Sales, LLC | $59.46 | 2023 | Vasoview Hemopro 2, Ultima Activator II Drive Mechanism |
| Lsi Solutions INC | $54.08 | 2024-2025 | Cor-Knot |
| Livanova USA, INC. | $52.14 | 2022-2023 | Tandemlife |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $40.20 | 2022-2023 | Xarelto |
| Lemaitre Vascular, INC. | $34.91 | 2021-2024 | Tyke, Patch, Pledget and Intracardiac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.22 | 2023 | Lifevest |
| Artivion, INC. | $23.44 | 2025 | Amds-Ascyrus Medical |
| Lightbody Medical Technologies INC | $23.28 | 2024 | |
| Convatec INC. | $22.39 | 2025 | |
| Merck Sharp & Dohme LLC | $21.25 | 2024 | Keytruda |
| Zimmer Biomet Holdings, INC. | $20.19 | 2025 | A&E Medical / Sternalock Xp Rigid Fixation System, Ribfix Blu Advantage, Sternalock |
| Helios Cardio INC | $20.13 | 2023 | |
| Bolton Medical INC | $19.36 | 2025 | Treo Abdominal Stent-Graft System |
| Csl Behring | $19.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mozer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.